Loxapine succinate - Generic Drug Details

What are the generic drug sources for loxapine succinate and what is the scope of freedom to operate?

Loxapine succinate is the generic ingredient in two branded drugs marketed by Elite Labs Inc, Lannett Co Inc, Rising, Watson Labs, and Teva Branded Pharm, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for loxapine succinate. Six suppliers are listed for this compound.

Summary for loxapine succinate

US Patents:	0
Tradenames:	2
Applicants:	5
NDAs:	8
Drug Master File Entries:	5
Finished Product Suppliers / Packagers:	6
Raw Ingredient (Bulk) Api Vendors:	77
Clinical Trials:	2
Patent Applications:	3,363
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for loxapine succinate
What excipients (inactive ingredients) are in loxapine succinate?	loxapine succinate excipients list
DailyMed Link:	loxapine succinate at DailyMed

See drug prices for loxapine succinate

Recent Clinical Trials for loxapine succinate

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Witten/Herdecke	Phase 2
Mylan Pharmaceuticals	Phase 1

See all loxapine succinate clinical trials

US Patents and Regulatory Information for loxapine succinate

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Branded Pharm	LOXITANE	loxapine succinate	CAPSULE;ORAL	017525-004	Approved Prior to Jan 1, 1982		DISCN	Yes	No
Rising	LOXAPINE SUCCINATE	loxapine succinate	CAPSULE;ORAL	076762-004	Nov 1, 2004		DISCN	No	No
Rising	LOXAPINE SUCCINATE	loxapine succinate	CAPSULE;ORAL	076762-001	Nov 1, 2004		DISCN	No	No
Rising	LOXAPINE SUCCINATE	loxapine succinate	CAPSULE;ORAL	076762-002	Nov 1, 2004		DISCN	No	No
Lannett Co Inc	LOXAPINE SUCCINATE	loxapine succinate	CAPSULE;ORAL	090695-003	Sep 26, 2011	AB	RX	No	No
Elite Labs Inc	LOXAPINE SUCCINATE	loxapine succinate	CAPSULE;ORAL	076868-001	Aug 4, 2005	AB	RX	No	No

Expired US Patents for loxapine succinate

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Teva Branded Pharm	LOXITANE	loxapine succinate	CAPSULE;ORAL	017525-001	Approved Prior to Jan 1, 1982
Teva Branded Pharm	LOXITANE	loxapine succinate	CAPSULE;ORAL	017525-004	Approved Prior to Jan 1, 1982
Teva Branded Pharm	LOXITANE	loxapine succinate	CAPSULE;ORAL	017525-003	Approved Prior to Jan 1, 1982
Teva Branded Pharm	LOXITANE	loxapine succinate	CAPSULE;ORAL	017525-002	Approved Prior to Jan 1, 1982